In recent years, a propensity score-matched multicenter retrospective analysis has reported that the addition of thoracic radiotherapy to chemotherapy and PD-L1 inhibitors improves ORR and OS in patients with ES-SCLC (34). This evidence concerns the gene CD274 and small cell lung carcinoma.